Related Experiment Video
Updated: Jun 11, 2026
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
A new paradigm for cancer therapeutics development
1Research Institute, National Cancer Center, Goyang, Korea. kimsooyoul@gmail.com
BMB Reports
|July 1, 2010
Summary
Cancer drug development in Korea faces challenges but offers opportunities. Collaboration and focusing on novel therapeutics can accelerate progress and bridge the development gap.
Area of Science:
- Oncology
- Drug Development
- Pharmacology
Background:
- Rising cancer incidence necessitates advanced treatment strategies.
- Molecular-targeted therapies are a key focus, but research efforts often overlap.
- A development gap exists between Korean and international cancer therapeutics programs.
Purpose of the Study:
- To review the current state of cancer drug development in Korea.
- To identify future directions and opportunities for advancement.
- To advocate for collaborative efforts to accelerate novel therapeutics development.
Main Methods:
- Review of existing cancer drug development landscape in Korea.
- Analysis of research efforts and potential for optimization.
- Highlighting the role of interdisciplinary collaboration and networking.
Main Results:
- Korea possesses skilled scientists but lacks a centralized validation and development center.
- Overlapping research efforts indicate a need for strategic resource allocation.
- The establishment of initiatives like the Drug Development Consortium shows potential for progress.
Conclusions:
- Focusing on novel drug candidate identification and optimization is crucial.
- Interdisciplinary collaboration and networking are essential for efficient cancer therapeutics development.
- Strategic initiatives can help Korea overcome development gaps and advance its pipeline.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...